Lionel Seltz
Finanzdirektor/CFO bei GENOMIC VISION
Ursprung des Netzwerks ersten Grades von Lionel Seltz
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Medical Specialties | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lionel Seltz
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
SANOFI | Biotechnology | Chief Tech/Sci/R&D Officer | |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Université de Montpellier | College/University | Doctorate Degree | |
Elaia Partners SAS
Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices. | Investment Managers | Private Equity Investor | |
The University of York | College/University | Chief Tech/Sci/R&D Officer | |
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder | |
University of Geneva | College/University | Graduate Degree | |
Weizmann Institute of Science | College/University | Doctorate Degree | |
École Normale Supérieure | College/University | Graduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
HealthCare Medical Technologies, Inc.
HealthCare Medical Technologies, Inc. Other Consumer ServicesConsumer Services HealthCare Medical Technologies, Inc. provides healthcare management services to health plans focused on obesity, diabetes, renal failure, heart disease, and high risk obstetrics. The company is headquartered in Sioux Falls, SD. | Other Consumer Services | Corporate Officer/Principal | |
TXCELL | Miscellaneous Commercial Services | President | |
University of Reims Champagne-Ardenne | College/University | Undergraduate Degree | |
ETHERA SA
ETHERA SA Medical SpecialtiesHealth Technology ETHERA SA provides diagnostic kits for indoor air pollution. It also develops solutions for measurement of chemical pollutants in the indoor air, especially for toxic volatile organic compounds. The firm's products include Profil'air modules, Profil'air sensors and Profil'air accessories. The company was founded by Yves Bigay, Thu-Hoa Tran-Thi and Sylvain Colomb in 2010 and is headquartered in Crolles, France. | Medical Specialties | Chief Executive Officer | |
Sorbonne Université | College/University | Undergraduate Degree | |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Director/Board Member | |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member | |
Universite Paris Cite | College/University | Doctorate Degree Graduate Degree |
Statistik
International
Frankreich | 16 |
Vereinigtes Königreich | 3 |
Schweiz | 2 |
Israel | 2 |
Vereinigte Staaten | 2 |
Sektoral
Consumer Services | 11 |
Health Technology | 7 |
Miscellaneous | 2 |
Finance | 2 |
Commercial Services | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Director/Board Member | 5 |
Chief Executive Officer | 4 |
Founder | 4 |
Graduate Degree | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Lionel Seltz
- Unternehmensverbindungen